Jesse Hunter currently serves as Executive Vice President, Mergers & Acquisitions and Chief Strategy Officer for Centene Corporation, a Fortune 51 multi-national healthcare enterprise. Since joining Centene in 2002, he has held multiple positions with increasing responsibility that have contribu ted significantly to the growth and success of the organization.
Mr. Hunter has over two decades of experience in healthcare finance, mergers and acquisitions, corporate development, strategy and operations. Prior to joining Centene, Mr. Hunter worked in mergers and acquisitions at Humana Inc. and for Healthcare Financial Partners, a publicly-traded specialty finance company.
Mr. Hunter received a Bachelor’s degree in finance from Miami University in Oxford, Ohio, and a Master of Business Administration degree from the Olin Business School at Washington University in St. Louis. In 2014, Mr. Hunter was recognized as a Distinguished Alumni from the Olin Business School.
Mr. Hunter is also committed to community service as evidenced by his leadership role in multiple organizations. Mr. Hunter serves as the President of the Board of Directors at the Center of Creative Arts (COCA). He is an advisor to the Community Health in Partnership Services (CHIPS), a free clinic providing services to uninsured individuals in the St. Louis Community. Additionally, he is a Board member for American Heritage Trees.
Mr. Hunter is a proud husband to wife Linda and father of Riley (15), Kate (12), and Jackson (11).
What is Jesse N. Hunter's net worth?
The estimated net worth of Jesse N. Hunter is at least $12.89 million as of April 28th, 2016. Mr. Hunter owns 216,329 shares of Centene stock worth more than $12,888,882 as of December 21st. This net worth approximation does not reflect any other assets that Mr. Hunter may own. Learn More about Jesse N. Hunter's net worth.
How do I contact Jesse N. Hunter?
Has Jesse N. Hunter been buying or selling shares of Centene?
Who are Centene's active insiders?
Centene's insider roster includes Andrew Asher (Exec. VP & CFO ), Andrew Asher (CFO), Orlando Ayala (Director), Shannon Bagley (EVP), Mark Brooks (EVP), Kenneth Burdick (EVP), Brandy Burkhalter (COO), Katie Casso (SVP), Christopher Coughlin (Director), Robert Ditmore (Director), Kenneth Fasola (President), Richard Gephardt (Director), Jesse Hunter (NASDAQ), Christopher Koster (SVP), Brent Layton (EVP), Sarah London (CEO & Director), Michael Neidorff (CEO), John Roberts (Director), Lori Robinson (Director), Theodore Samuels, II (Director), Jeffrey Schwaneke (CFO), David Thomas (EVP), Tommy Thompson (Director), and Colin Toney (EVP). Learn More on Centene's active insiders.
Are insiders buying or selling shares of Centene?
In the last twelve months, Centene insiders bought shares 5 times. They purchased a total of 45,010 shares worth more than $2,660,275.53. In the last twelve months, insiders at the sold shares 4 times. They sold a total of 30,878 shares worth more than $2,363,286.50. The most recent insider tranaction occured on December, 18th when Director Thomas Greco bought 17,000 shares worth more than $1,015,750.00. Insiders at Centene own 0.3% of the company.
Learn More about insider trades at Centene. Information on this page was last updated on 12/18/2024.
